WE-AB-207B-06: Dose and Biological Uncertainties in Sarcoma.

Abstract

PURPOSE To understand the clinical impact of key uncertainties in proton therapy potentially affecting the analysis of clinical trials, namely the assumption of using a constant relative biological effectiveness (RBE) of 1.1 compared to variable RBE for proton therapy and the use of analytical dose calculation (ADC) methods. METHODS Proton dose… (More)
DOI: 10.1118/1.4957787

Topics

  • Presentations referencing similar topics